US Stock MarketDetailed Quotes
CYTH Cyclo Therapeutics
- 0.679
- +0.002+0.27%
Close Nov 26 16:00 ET
- 0.680
- +0.001+0.15%
Post 20:01 ET
19.53MMarket Cap-754P/E (TTM)
0.686High0.600Low28.68KVolume0.660Open0.677Pre Close18.51KTurnover0.18%Turnover RatioLossP/E (Static)28.77MShares2.11552wk High-1.45P/B10.71MFloat Cap0.59552wk Low--Dividend TTM15.77MShs Float17.750Historical High--Div YieldTTM12.67%Amplitude0.595Historical Low0.645Avg Price1Lot Size
Cyclo Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -102.72%-8.19M | -10.62%-3.85M | -41.46%-6.18M | -7.08%-16.19M | -56.36%-4.29M | -27.02%-4.04M | 20.14%-3.48M | 9.52%-4.37M | -0.73%-15.11M | -5.17%-2.75M |
| Net income from continuing operations | -85.12%-8.83M | -29.00%-5.98M | 13.26%-4.34M | -29.81%-20.06M | -13.29%-5.64M | -12.35%-4.77M | -34.31%-4.64M | -80.66%-5.01M | -8.15%-15.45M | -78.36%-4.98M |
| Operating gains losses | --0 | --0 | --11.81K | ---- | ---- | ---- | ---- | ---- | ---158.52K | --0 |
| Depreciation and amortization | -54.82%2.18K | -54.82%2.18K | -54.82%2.18K | -1.05%19.28K | -1.05%4.82K | -6.04%4.82K | 1.65%4.82K | 1.65%4.82K | 15.77%19.48K | 15.76%4.87K |
| Other non cash items | ---- | ---- | --92.13K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | -309.87%-1.1M | 18.47%1.15M | -492.04%-2.12M | 6,461.58%3.06M | -50.72%1.03M | -45.65%523.3K | 191.92%967.49K | 126.33%540.36K | 96.08%-48.15K | 479.41%2.09M |
| -Change in receivables | 51.74%-103.95K | -128.98%-12.42K | 166.97%51.06K | -115.75%-67.39K | -41.02%181.38K | -680.24%-215.37K | 114.69%42.83K | -120.34%-76.23K | 196.36%427.85K | 292.01%307.55K |
| -Change in inventory | -81.71%4.92K | -80.88%1.5K | 18.29%11.82K | -95.10%-52.78K | -685.84%-97.52K | 355.49%26.89K | 119.85%7.85K | 56.62%9.99K | -358.35%-27.05K | -36.85%16.65K |
| -Change in prepaid assets | -581.24%-891.33K | 129.75%201.93K | -54.37%-612.69K | 74.12%-64.32K | -28.79%826.21K | 16.89%185.21K | -1,497.92%-678.85K | 75.44%-396.91K | 79.33%-248.56K | 825.37%1.16M |
| -Change in payables and accrued expense | -120.49%-107.86K | -40.13%955.2K | -256.56%-1.57M | 1,719.66%3.25M | -80.03%121.79K | -32.15%526.41K | 307.31%1.6M | 222.73%1M | -149.09%-200.39K | -6.96%609.81K |
| -Change in other working capital | ---- | ---- | ---- | --2.04K | --154 | --155 | 144.93%155 | 202.34%1.57K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -102.72%-8.19M | -10.62%-3.85M | -41.46%-6.18M | -7.08%-16.19M | -56.36%-4.29M | -27.02%-4.04M | 20.14%-3.48M | 9.52%-4.37M | -0.73%-15.11M | -5.17%-2.75M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -106.34%-2.42K | 157.52%38.17K | 0 | |||||||
| Net PPE purchase and sale | ---- | ---- | ---- | 83.96%-2.42K | ---- | ---- | ---- | ---- | 32.95%-15.09K | --0 |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 42.69%53.26K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | -106.34%-2.42K | ---- | ---- | ---- | ---- | 157.52%38.17K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 59.92%8M | -42.00%1.97M | -101.85%-69.28K | 352,373.00%23.89M | 11.74M | 5M | 3.41M | 55,107.98%3.74M | -99.96%6.78K | 0 |
| Net issuance payments of debt | --8M | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 200.00%6.78K | --0 |
| Net common stock issuance | --0 | --0 | --0 | --9.74M | --509.73K | --5M | --2.9M | --1.33M | --0 | --0 |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | --4.8M | --1.88M | --1.48K | --509.79K | --2.41M | --0 | --0 |
| Net other financing activities | ---1.4K | ---25.23K | ---69.28K | --9.35M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 59.92%8M | -42.00%1.97M | -101.85%-69.28K | 352,373.00%23.89M | --11.74M | --5M | --3.41M | 55,107.98%3.74M | -99.96%6.78K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 33.31%1.12M | 227.28%3M | 499.10%9.25M | -90.71%1.54M | -58.00%1.8M | -88.71%841.53K | -92.24%915.18K | -90.71%1.54M | 29.32%16.61M | -49.18%4.29M |
| Current changes in cash | -120.18%-193.8K | -2,443.74%-1.87M | -895.06%-6.25M | 151.12%7.7M | 371.04%7.44M | 130.36%960.28K | 98.31%-73.65K | 86.95%-628.24K | -500.08%-15.07M | -133.61%-2.75M |
| End cash Position | -48.50%928.01K | 33.31%1.12M | 227.28%3M | 499.10%9.25M | 499.10%9.25M | -58.00%1.8M | -88.71%841.53K | -92.24%915.18K | -90.71%1.54M | -90.71%1.54M |
| Free cash flow | -102.72%-8.19M | -10.62%-3.85M | -41.46%-6.18M | -6.99%-16.19M | -56.45%-4.3M | -26.61%-4.04M | 20.14%-3.48M | 9.61%-4.37M | -0.68%-15.13M | -5.17%-2.75M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data